Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

NCT01728220 ·Status: COMPLETED ·Phase: PHASE2

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis

NCT03727451 ·Status: COMPLETED ·Phase: PHASE2

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

NCT02267655 ·Status: COMPLETED ·Phase: PHASE1

Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide

NCT02170519 ·Status: TERMINATED ·Phase: PHASE4

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide

NCT01092559 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

NCT00626028 ·Status: COMPLETED ·Phase: PHASE3

Study on the Use of Inhaled NO (iNO)

NCT02821156 ·Status: COMPLETED

Inhaled Nitrite in Subjects With Pulmonary Hypertension

NCT01431313 ·Status: COMPLETED ·Phase: PHASE2

Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH

NCT02734953 ·Status: COMPLETED ·Phase: PHASE2

Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

NCT04266197 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide

NCT04231084 ·Status: COMPLETED ·Phase: PHASE4

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

NCT05356052 ·Status: AVAILABLE

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

NCT03015402 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT01725256 ·Status: TERMINATED ·Phase: PHASE2

Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension

NCT00352430 ·Status: COMPLETED ·Phase: PHASE1

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

NCT05867914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

NCT03794583 ·Status: TERMINATED ·Phase: PHASE3

An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

NCT02633293 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Inhaled Nitric Oxide in Pulmonary Embolism

NCT00565253 ·Status: COMPLETED ·Phase: PHASE2

Safety of SonoVue on Pulmonary Hemodynamics

NCT01306292 ·Status: COMPLETED ·Phase: PHASE2

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

NCT01265888 ·Status: COMPLETED ·Phase: PHASE2

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program

NCT01389206 ·Status: COMPLETED

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

NCT00250640 ·Status: COMPLETED

Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension

NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2